Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2007
12/05/2007CN101081224A Stable extended release oral dosage composition
12/05/2007CN101081219A Composition containing taxane genus compound, the method for preparing the same and the use thereof
12/05/2007CN101081218A Rapid-disintegrated oral film and method for making same
12/05/2007CN101081217A Slow-release small pill prparation containing huperzine A and method for making same
12/05/2007CN101081215A Conotoxin SO3 nanometer grain composition and method of making the same and the application thereof
12/05/2007CN101081213A Butane diacid(5-androstene-17-ketone- 3beta -hydroxyl group ) diester solid dispersoid and method for making same and applications thereof
12/05/2007CN101081211A Water indissoluble carbostyrile compound injection and method for preparing the same
12/05/2007CN101081209A Anticancer composition containing tyrosine kinase restraining agent and taxane
12/05/2007CN101081208A Slow-release injection containing tyrosine kinase restraining agent and platinum compound
12/05/2007CN101081207A Medicine composition containing tyrosine kinase restraining agent
12/05/2007CN101081206A Anti-cancer medicine composition containing tyrosine kinase restraining agent
12/05/2007CN101081205A Instant jelly glue for eyes
12/05/2007CN101081204A Method for preparation of cross-linking hyaluronic acid sodium jelly glue implanted in eyes
12/05/2007CN101081203A Method of increasing testosterone and related steroid concentrations in women
12/05/2007CN100352921C Compositions and methods for identifying antigens which elicit an immune response
12/05/2007CN100352837C Pegylated T1249 polypeptide
12/05/2007CN100352810C Fumagillol derivatives and processes for preparing the same
12/05/2007CN100352510C Therapeutically useful triethyleneglycol cholesteryl oligonucleotides
12/05/2007CN100352509C Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
12/05/2007CN100352508C Block polymer for eyes
12/05/2007CN100352500C Stable liquid formulations of antibodies
12/05/2007CN100352498C Three dimensional eye patch for treating eye wrinkles an its preparation method
12/05/2007CN100352495C Stabilized pharmaceutical composition in lyophilized form
12/05/2007CN100352448C Methods and compositions for the prevention of tolerance to medications
12/05/2007CN100352445C A method of treating human skin and a skin care composition for use in such a method
12/05/2007CN100352444C A process for the preparation of piroxicam: beta-cyclodextrin inclusion compounds
12/05/2007CN100352443C Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist
12/05/2007CN100352440C Orally dispersible pharmaceutical piribedil composition
12/05/2007CN100352436C Oral suspension of tegaserod
12/05/2007CN100352435C Dry syrup preparation of procaterol comprising ascorbinic acid and citric acid
12/05/2007CN100352432C Nateglinide-containing preparation
12/05/2007CN100352431C Pharmaceutical salts
12/05/2007CN100352427C Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight
12/05/2007CN100352426C Method for preparing polymer micelle pharmaceutical preparation containing drug for injection
12/04/2007US7304075 Aqueous solution of sitafloxacin and sodium chloride; photostable microorganisms
12/04/2007US7304037 Cytostatic conjugates with integrin ligands
12/04/2007US7304035 Stimulation of bone growth with thrombin peptide derivatives
12/04/2007US7304032 CD-10 activated prodrug compounds
12/04/2007US7303926 Causing necrosis or apoptosis of target tissue using both type 1 and type 2 mechanisms
12/04/2007US7303768 Gastrointestinal disorders; antiulcer agents
12/04/2007US7303764 For therapy of psychosis, acute mania or mild anxiety states
12/04/2007US7303762 Absorption enhancers
12/04/2007US7303760 Method for treating multi-drug resistant tumors
12/04/2007US7303755 Use of sodium and potassium salts of citric, phosphoric, carbonic and tartaric acid and arginine and lysine as stabilizer of the antibiotic Fosfomycin Tromethamine
12/04/2007US7303750 Methods to improve immunogenicity of antigens and specificity of antibodies
12/04/2007CA2321826C Pharmaceutical formulations of taxanes
12/04/2007CA2283295C Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels
12/04/2007CA2265815C Formulations for topical use
12/04/2007CA2265767C Stable pharmaceutical composition including 4,5-epoxy-morphinan derivative
12/04/2007CA2263705C Novel sandwich liposome complexes comprising a biologically active agent
12/04/2007CA2255891C Compositions and methods for treating or preventing diseases of body passageways
12/04/2007CA2230950C Solid drug forms obtainable by extrusion of an isomalt-containing polymer/active ingredient melt
12/04/2007CA2201121C Bilayer stabilizing components and their use in forming programmable fusogenic liposomes
12/04/2007CA2201120C Polyethylene glycol modified ceramide lipids and liposome uses thereof
12/04/2007CA2192965C Anandamide analogue compositions and method of treating intraocular hypertension using same
11/2007
11/29/2007WO2007136633A2 Gel-formulations of hydrophobic photosensitizers for mucosal applications
11/29/2007WO2007136134A1 Process for producing polymer micelle enclosing hydrophobic drug
11/29/2007WO2007136067A1 External preparation for skin
11/29/2007WO2007135910A1 Polymer conjugate of podophyllotoxin
11/29/2007WO2007135774A1 Oral liquid preparation composition containing herbal medicine
11/29/2007WO2007135766A1 Ointment for amelioration or treatment of oral tumor
11/29/2007WO2007135118A1 Soluble, stable insulin-containing formulations
11/29/2007WO2007135114A1 Hydrogels of polysaccharide mixtures for tissue engineering and as carriers of active compounds
11/29/2007WO2007134845A2 Olanzapine pharmaceutical composition
11/29/2007WO2007134354A1 Pharmaceutical formulation
11/29/2007WO2007085629A3 Use of hyaluronic acid as a carrier molecule for?different classes of therapeutic active agents
11/29/2007WO2007076295A3 Nanoclusters for delivery of therapeutics
11/29/2007WO2007073888A3 Pharmaceutical composition containing donepezil hydrochloride, tablets produced therefrom and method for producing the same
11/29/2007WO2007065846A3 Use of polyvinyl lactam-polyoxyalkylene block copolymers as solubilisers for poorly water-soluble compounds
11/29/2007WO2007052153A3 Food grade antioxidant and flavorant from roasted wheat malt
11/29/2007WO2007050379A3 Preventing bacterial or viral infectivity and composition containing infection preventing additive
11/29/2007WO2007042470A3 Antithrombotic compound
11/29/2007WO2007042469A3 Anticoagulant antithrombotic dual inhibitors comprising a biotin label
11/29/2007WO2006138572A3 Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates
11/29/2007WO2006107311A3 Biocompatible polymeric vesicles self assembled from triblock copolymers
11/29/2007WO2006084089A3 Process for the preparation of polymer conjugates
11/29/2007WO2005116226A3 Nanoparticles comprising rna ligands
11/29/2007WO2003067952A3 Glucosamine-polyacrylate inter-polymer complex and applications thereof
11/29/2007US20070276088 Protein-polymer conjugate prepared by reacting a bromoisobutyrate-modified ligand initiator, such as biotin, with the protein to form initiator-modified locations on it, and polymerizing a monomer, such as N-isopropylacrylamide or methoxy(poly)oxyethylene methacrylate, to form the conjugate; streptavidin
11/29/2007US20070276029 Glutamine-Containing Energy Imparting Amino Acid Composition or Amino Acid Solution
11/29/2007US20070276008 Pharmaceutical formulation comprising glycine as a stabilizer
11/29/2007US20070276004 Pharmaceutical Composition Comprising an Immunosuppressant for Use in the Treatment of Skin Diseases
11/29/2007US20070275992 Methods for synthesizing heterocycles and therapeutic use of the heterocycles for cancers
11/29/2007US20070275903 oligopeptide conjugates; cleavable by trouase such as Thimet oligopeptidase; antitumor agents
11/29/2007US20070275900 HIV protease inhibitory compounds with ameliorated solubility and/or bioavailability; conjugates of therapeutic compound and a peptide wherein the conjugate is cleavable by dipeptidyl-peptidases
11/29/2007US20070275890 Chaperonin 10 Modulation Of Toll-Like Receptor-Inducible Cytokine And Chemokine Secretion
11/29/2007US20070275878 No-modified hemoglobins and uses therefor
11/29/2007US20070275853 Solid Products with Improved Stability and Method for Producing the Same
11/29/2007US20070275108 Life Span Managment
11/29/2007US20070275074 Controlled agglomeration
11/29/2007US20070275069 Hydrophobic biomolecular structure
11/29/2007US20070275058 Tablet Quickly Disintegrating in Oral Cavity
11/29/2007US20070275055 Compositions capable of facilitating penetration across a biological barrier
11/29/2007US20070275054 Novel composition and use
11/29/2007US20070275036 Avian follistatin product
11/29/2007US20070275007 Carbohydrate Antigen-Nanoparticle Conjugates and Uses Thereof as Antimetastatic Agents in Treating Cancer
11/29/2007US20070275006 Iridoid glycoside composition
11/29/2007US20070275005 Use of Lipopeptides for Activating T Lymphocytes Through the Skin
11/29/2007US20070274953 Photochemical internalization for delivery of molecules into the cytosol
11/29/2007US20070274950 Interferon-alpha polypeptides and conjugates
1 ... 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 ... 1712